Article

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

2023-03-29

Abstract excerpt

<h4>Background: </h4> Percutaneous coronary intervention (PCI) is one of the most performed well-succeeded therapeutic procedures worldwide, reducing symptoms and improving quality of life. Lidocaine associated with gelatinase neutrophilic acid (NGAL) is a biomarker of acute kidney injury (AKI) produced early after an ischemic renal insult. Osmotic diuresis and the vasoconstriction of the afferent arteriole promot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5382dcb-aead-52d3-8612-c0807dda7ef4
DOI: 10.21203/rs.3.rs-2530647/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studyDOI 10.21203/rs.3.rs-2530647/v1Read

Efficacy and safety of SGLT2 inhibitors in the treatment of heart failure-May raise creatinine levels in patients: A meta-analysisSemantic proximity Read

Human Urinary Kallidinogenase (HUK) Alleviates Myocardial Injury in Rats with Coronary Microembolism Through PI3K/Akt/FoxO1 Signaling Pathway.Semantic proximity Read

Study on the Intervention of α-Lipoic Acid in Patients with Type 2 Diabetes Mellitus after CAG or PCI Compared with Contrast-Induced NephropathySemantic proximity Read

Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity Read

SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeSemantic proximity Read

Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradoxSemantic proximity Read

Update on the use of Sodium Glucose Cotransporter Type 2 inhibitors in kidney transplant patientsSemantic proximity Read

Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity Read

Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and MacrophagesSemantic proximity Read

Development of SGLT1 and SGLT2 inhibitors.Semantic proximity Read

The effect of SGLT2 inhibitor on the gene expression and metabolomic profile of podocytesSemantic proximity Read

Ticagrelor Monotherapy in Patients with Concomitant Diabetes Mellitus and Chronic Kidney Disease: A post hoc analysis of the GLOBAL LEADERS TrialSemantic proximity Read